
Neoadjuvant eftilagimod alfa, pembrolizumab, and radiotherapy produced an 81.1% 12-month DFS rate in high-risk, resectable soft tissue sarcoma.
A 42-year-old woman presents with uterine bleeding. After further evaluation, a biopsy is performed. What is your diagnosis?
A 42-year-old woman presents with uterine bleeding. After further evaluation, a biopsy is performed. According to the histopathology image below, what is your diagnosis?
What is your diagnosis?






